Back to trial details

Intake questionnaire

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

Applying to The University of Alabama · Birmingham, Alabama

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Ovarian Cancer?
3. Are you able to travel to Birmingham for study visits?